Author: Zou, Xiaojing; Fang, Minghao; Li, Shusheng; Wu, Liang; Gao, Bing; Gao, Hong; Ran, Xiao; YiBian,; Li, Renjie; Yu, Shanshan; Ling, Jianmin; Li, Donghui; Tian, Deying; Huang, Jiao
Title: Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection Cord-id: g1iqhsdk Document date: 2020_6_15
ID: g1iqhsdk
Snippet: Summary Background and aims Coronavirus disease 2019 (COVID-19) is a major global health threat. We aimed to describe the characteristics of liver function in patients with SARS-CoV-2 and chronic hepatitis B virus (HBV) co-infection. Methods We enrolled all adult patients with SARS-CoV-2 and chronic HBV co-infection admitted to Tongji Hospital from February 1 to February 29, 2020. Data of demographic, clinical characteristics, laboratory tests, treatments, and clinical outcomes were collected. T
Document: Summary Background and aims Coronavirus disease 2019 (COVID-19) is a major global health threat. We aimed to describe the characteristics of liver function in patients with SARS-CoV-2 and chronic hepatitis B virus (HBV) co-infection. Methods We enrolled all adult patients with SARS-CoV-2 and chronic HBV co-infection admitted to Tongji Hospital from February 1 to February 29, 2020. Data of demographic, clinical characteristics, laboratory tests, treatments, and clinical outcomes were collected. The characteristics of liver function and its relation with the severity and prognosis of disease were described. Results Of 105 SARS-CoV-2 and chronic HBV co-infected patients, elevated levels of liver test were seen in several patients at admission, including elevated levels of alanine aminotransferase (22,20.95%), aspartate aminotransferase (29, 27.62%), total bilirubin (7, 6.67%), gamma-glutamyl transferase (7, 6.67%) and alkaline phosphatase (1, 0.95%). The values of the indices mentioned above increased substantially during hospitalization (all P<0.05). 14 (13.33%) patients developed liver injury. Most of them (10, 71.43%) recovered after 8 (range 6-21) days. Notably, 4 (28.57%) patients rapidly progressed to acute-on-chronic liver failure. The proportion of severe COVID-19 was higher in patients with liver injury (P= 0.042). Complications including ACLF, acute cardiac injury and shock happened more frequently in patients with liver injury (all P<0.05). The mortality was higher in individuals with liver injury (28.57% vs 3.30%, P=0.004). Conclusion Liver injury in patients with SARS-CoV-2 and chronic HBV co-infection was associated with severity and poor prognosis of disease. During the treatment of COVID-19 in chronic HBV-infected patients, liver function should be taken seriously and evaluated frequently.
Search related documents:
Co phrase search for related documents- abnormal level and acute liver injury: 1
- abnormal level and acute respiratory distress syndrome: 1, 2
- abnormal level and admission prior: 1
- abnormal level and liver failure: 1
- abnormal liver and acute cardiac injury: 1, 2
- abnormal liver and acute liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abnormal liver and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
- abnormal liver and admission prior: 1, 2
- abnormal liver and liver condition: 1, 2, 3
- abnormal liver and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- abnormal liver test and acute liver injury: 1
- abnormal liver test and liver condition: 1
- abnormal liver test and liver failure: 1
- aclf chronic acute liver failure and acute liver injury: 1
- aclf chronic acute liver failure and liver condition: 1
- aclf chronic acute liver failure and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute cardiac injury and admission prior: 1
- acute cardiac injury and liver failure: 1, 2, 3, 4, 5, 6
- acute liver injury and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date